Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model

Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model

<p>Abstract</p> <p>Background</p> <p>The treatment paradigm in advanced renal cell carcinoma (RCC) has changed in the recent years. Sunitinib has been established as a new standard for first-line therapy. We studied the prognostic significance of baseline characteristic...

Full description

Bibliographic Details
Main Authors: Christodoulou Christos, Skolarikos Andreas, Xanthakis Ioannis, Stravodimos Kostas, Anastasiou Ioannis, Kontovinis Loukas, Andreadis Charalambos, Papazisis Kostas, Timotheadou Eleni, Malettou Lia, Lainakis George, Lampaki Sofia, Karadimou Alexandra, Bamias Aristotelis, Syrigos Kostas, Papandreou Christos, Razi Evangelia, Dafni Urania, Fountzilas George, Dimopoulos Meletios A
Format: Article
Language:English
Published: BMC 2010-02-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/10/45

Internet

http://www.biomedcentral.com/1471-2407/10/45

Similar Items